Net gamma exposure for Ligand Pharmaceuticals Inc (LGND) options was positive at the Nov 4, 2026 close, about $242.83K per 1% move in the stock. It has been positive on 20 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for LGND, 2026-11-20(m), calls & puts
Gamma Exposure Stats
Showing results for LGND, 2026-11-20(m), calls & puts
Net Gamma Exposure by Expiration
Showing results for LGND, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
LGND Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is LGND gamma exposure positive or negative?
Ligand Pharmaceuticals net gamma exposure was positive on Nov 4, 2026, at $242.83K. It has been positive on 20 of the last 20 trading days.
How has LGND gamma exposure changed recently?
Ligand Pharmaceuticals net gamma exposure went from $78.87K on Oct 7, 2026 to $242.83K on Nov 4, 2026. That is its highest reading in 12 weeks. See the LGND gamma exposure history for a longer view.
What is Ligand Pharmaceuticals Inc?
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine.